Core Viewpoint - Bath & Body Works, Inc. is facing a class action lawsuit due to significant declines in financial performance and misleading statements regarding its business strategy during the class period from June 4, 2024, to November 19, 2025 [1][7]. Financial Performance - On August 28, 2025, Bath & Body Works reported Q2 2025 earnings per diluted share of $0.30, a decline of 55.8% year over year, and net income of $64 million, down 57.9% year over year [3]. - The company cut its full-year guidance for earnings per diluted share by $0.03, adjusting it to a range of $3.28 to $3.53 [3]. - On November 20, 2025, the company reported Q3 2025 revenue declined by 1% year over year, missing guidance of 1-3% growth, and net income fell 26% to $77 million [5]. - The full-year guidance for net sales was slashed from a previously positive 1.5%-2.7% to a negative "high single digits," and expected earnings per diluted share were reduced to "at least $2.83" [5]. Stock Performance - Following the Q2 2025 results announcement, Bath & Body Works' stock price fell by $2.18, or 6.9%, closing at $29.36 per share on August 28, 2025 [4]. - After the Q3 2025 results, the stock price dropped by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [6]. Lawsuit Details - The class action lawsuit alleges that the company made materially false and misleading statements and failed to disclose adverse facts about its business and operations [7]. - Specific allegations include the failure of the company's strategy of "adjacencies, collaborations and promotions" to grow the customer base and the reliance on brand collaborations to mask weak financial results [7]. - The lawsuit claims that the company was unlikely to meet its previously issued financial guidance due to these issues [7]. Participation in the Lawsuit - Investors who purchased Bath & Body Works securities during the class period can file a lead plaintiff motion by March 16, 2026, if they meet certain legal requirements [8].

CoreWeave, Inc. (NASDAQ: CRWV) - The class action lawsuit alleges that during the class period from March 28, 2025, to December 15, 2025, defendants made materially false and misleading statements regarding the company's business and operations [2] - Specifically, it is claimed that defendants overstated CoreWeave's ability to meet customer demand and understated the risks associated with reliance on a single third-party data center supplier [2] - The lawsuit suggests that these misrepresentations were likely to have a material negative impact on the company's revenue, rendering the defendants' positive statements misleading [2] Bath & Body Works, Inc. (NYSE: BBWI) - The class action lawsuit covers the period from June 4, 2024, to November 19, 2025, alleging that defendants made materially false and misleading statements about the company's growth strategies [3] - It is claimed that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected net sales growth [3] - The lawsuit indicates that as the strategy faltered, the company relied on brand collaborations to mask weak financial results, leading to a failure to meet previously issued financial guidance [3] Smart Digital Group Limited (NASDAQ: SDM) - The class action lawsuit pertains to the period from May 5, 2025, to September 26, 2025, alleging that defendants made materially false and misleading statements regarding market manipulation and fraudulent promotion schemes [4] - It is claimed that insiders used offshore accounts to facilitate coordinated share dumping during a price inflation campaign, which was not disclosed to investors [4] - The lawsuit highlights that the company's public statements omitted risks related to fraudulent trading and market manipulation, which could lead to a suspension of trading by regulatory bodies [4]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works, Inc. due to allegations of misleading statements and failure to disclose critical information regarding the company's financial performance and business strategy [2][5]. Financial Performance - Bath & Body Works reported a disappointing third quarter for 2025, with a 1% year-over-year decline in revenue, missing prior guidance of 1-3% growth, and a 26% drop in net income to $77 million [6]. - The company significantly reduced its full-year earnings per diluted share outlook from a range of $3.28 to $3.53 to "at least $2.83" [6]. Business Strategy - The complaint alleges that the company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow the customer base and did not deliver the expected growth in net sales [5]. - Bath & Body Works admitted that its previous focus on this strategy led to reduced investment in core categories and an overreliance on brand collaborations and promotions to mask weak financial results [6]. Stock Market Reaction - Following the announcement of disappointing financial results and the acknowledgment of strategic failures, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance and Stock Impact - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9%, from $31.54 to $29.36 [6]. - Following the Q3 2025 financial results on November 20, 2025, which included a further reduction in full year guidance and acknowledgment that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8%, from $21.04 to $15.82 [7]. Legal Proceedings - Investors have until March 13, 2026, to request to lead the case in the ongoing lawsuit, which is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in the U.S. District Court for the Southern District of Ohio [3].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. securities for the period between June 4, 2024, and November 19, 2025, due to alleged misleading statements and failure to disclose critical information regarding the company's financial performance and strategies [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Bath & Body Works made materially false and misleading statements about its business strategies and financial guidance, which led to investor damages when the truth was revealed [5]. - The lawsuit highlights that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow its customer base or deliver the expected net sales growth [5]. - It is stated that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results, ultimately leading to a failure to meet previously issued financial guidance [5]. Group 2: Participation Information - Investors who purchased Bath & Body Works securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by March 16, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance and Stock Impact - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the release of Q3 2025 financial results on November 20, 2025, which included a further reduction in full-year guidance and acknowledgment that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22, or 24.8%, from $21.04 to $15.82 per share [7]. Legal Proceedings - Investors have until March 13, 2026, to request to lead the case in the ongoing lawsuit, which is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in the U.S. District Court for the Southern District of Ohio [3].

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming March 16, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Bath & Body Works, Inc. ("Bath & Body Works†or the "Company†) (NYSE: BBWI) securities between June 4, 2024 and November 19, 2025, inclusive (the "Class Period†). Bath & Body Works investors have until March 16, 2026 to file a lead plaintiff motion. ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. for failing to disclose critical information regarding its business strategy and financial performance during the class period from June 4, 2024, to November 19, 2025 [2][6]. Allegation Details - The lawsuit alleges that Bath & Body Works did not disclose that its strategy of pursuing "adjacencies, collaborations and promotions" was ineffective in growing its customer base and did not deliver the expected growth in net sales [6]. - It is claimed that as the strategy faltered, the company relied on brand collaborations to mask weak financial results and was unlikely to meet its previously issued financial guidance [6]. - On November 20, 2025, the company reported disappointing third-quarter results, with a 1% year-over-year revenue decline, missing the guidance of 1-3% growth, and a 26% drop in net income to $77 million [6]. Financial Performance - Bath & Body Works reduced its full-year guidance for net sales and cut expected earnings per diluted share from $3.28 to "at least $2.83" [6]. - Following the announcement of its underperformance and new business strategy, the stock price fell by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [6]. Next Steps - Investors who purchased Bath & Body Works shares and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for more information regarding their rights and potential claims [4].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bath & Body Works To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Bath & Body Works between June 4, 2024 and November 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 15, 2026 (GLOBE N ...

Core Viewpoint - Bath & Body Works, Inc. is facing a class action lawsuit due to alleged misleading statements regarding its growth strategy and financial performance during the specified class period from June 4, 2024, to November 19, 2025 [1] Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, and during the relevant period, it explored product categories beyond its core business, including men's products, lip care, hair care, and laundry items [3] Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, which led to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 [5] - Following the Q3 2025 results released on November 20, 2025, the company announced further cuts to its full-year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22, or 24.8%, from $21.04 to $15.82 [6] Strategic Misalignment - Bath & Body Works claimed that customers were responding favorably to its innovation and adjacencies, asserting that its strategy was effective in driving topline growth; however, it was alleged that the strategy did not deliver the expected growth in net sales or expand the customer base [4]